Tetraphase Pharmaceuticals (TTPH) Reaches $6.64 After 8.00% Up Move; Eaton Vance Short Duration Diversified Income Fund (EVG) Sentiment Is 0.5

November 22, 2017 - By Linda Rogers

The stock of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) is a huge mover today! About 77,819 shares traded. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) has risen 106.58% since November 22, 2016 and is uptrending. It has outperformed by 89.88% the S&P500.The move comes after 8 months positive chart setup for the $341.65M company. It was reported on Nov, 22 by Barchart.com. We have $7.17 PT which if reached, will make NASDAQ:TTPH worth $27.33 million more.

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. The company has market cap of $248.88 million. The Fund’s primary investment objective is to provide a high level of current income, with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. It currently has negative earnings. The Fund holds investments in various sectors, such as aerospace and defense, air transport, automotive, beverage and tobacco, building and development, business equipment and services, cable and satellite television, chemicals and plastics, clothing/textiles, containers and glass products, drugs, cosmetics/toiletries, ecological services and equipment, electronics/electrical, equipment leasing, financial intermediaries, food products, food/drug retailers, forest products, healthcare, food service, home furnishings, industrial equipment, insurance, leisure goods/activities/movies, lodging and casinos, and gas and oil.

Among 13 analysts covering Tetraphase Pharmaceuticals (NASDAQ:TTPH), 5 have Buy rating, 0 Sell and 8 Hold. Therefore 38% are positive. Tetraphase Pharmaceuticals has $57 highest and $8 lowest target. $24.13’s average target is 263.40% above currents $6.64 stock price. Tetraphase Pharmaceuticals had 25 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, June 21 by BMO Capital Markets. SunTrust downgraded the stock to “Neutral” rating in Wednesday, September 9 report. The stock has “Market Perform” rating by JMP Securities on Wednesday, September 9. Wedbush downgraded the shares of TTPH in report on Wednesday, September 9 to “Neutral” rating. The rating was downgraded by Gabelli to “Neutral” on Friday, May 13. The company was downgraded on Wednesday, September 9 by Nomura. The firm earned “Hold” rating on Wednesday, September 9 by Cantor Fitzgerald. The stock of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) earned “Market Perform” rating by BMO Capital Markets on Tuesday, April 12. The rating was maintained by Brean Capital with “Buy” on Thursday, August 6. The stock has “Neutral” rating by Robert W. Baird on Wednesday, September 9.

Analysts await Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) to report earnings on March, 14. They expect $-0.64 EPS, down 4.92% or $0.03 from last year’s $-0.61 per share. After $-0.63 actual EPS reported by Tetraphase Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts 1.59% negative EPS growth.

Investors sentiment decreased to 1.31 in 2017 Q2. Its down 0.16, from 1.47 in 2017Q1. It dropped, as 13 investors sold Tetraphase Pharmaceuticals Inc shares while 19 reduced holdings. 17 funds opened positions while 25 raised stakes. 20.56 million shares or 13.43% more from 18.13 million shares in 2017Q1 were reported. 63,597 were reported by Boothbay Fund Management Ltd Liability. Federated Investors Incorporated Pa holds 206,574 shares. State Board Of Administration Of Florida Retirement owns 19,923 shares for 0% of their portfolio. Wells Fargo Mn stated it has 0% of its portfolio in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). 15,000 were accumulated by Wade G W And Incorporated. D E Shaw And has 130,320 shares for 0% of their portfolio. 99,919 were accumulated by Tiaa Cref Investment Mgmt Ltd Co. Blackrock stated it has 2.37 million shares. Parametric Portfolio Llc invested in 0% or 69,872 shares. Axa holds 18,500 shares. United Kingdom-based Legal And General Public Limited Liability Corporation has invested 0% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Ecor1 Capital Limited Liability Corp holds 633,400 shares. Bnp Paribas Arbitrage invested in 3,747 shares. California State Teachers Retirement Sys reported 0% of its portfolio in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Vanguard Gp invested in 1.42 million shares or 0% of the stock.

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $341.65 million. The Firm uses its chemistry technology to create antibiotics for multidrug-resistant infections. It currently has negative earnings. The Firm is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections.

Sit Investment Associates Inc holds 1.33% of its portfolio in Eaton Vance Short Duration Diversified I for 3.81 million shares. Wfg Advisors Lp owns 383,700 shares or 1.22% of their US portfolio. Moreover, Rivernorth Capital Management Llc has 0.29% invested in the company for 267,675 shares. The Florida-based Naples Global Advisors Llc has invested 0.14% in the stock. Institute For Wealth Management Llc., a Colorado-based fund reported 20,349 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.